Effect of using enzyme which boost the activity of minoxidil in the treatment of Male baldness
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2024/08/072403
- Lead Sponsor
- Dr. Ranjith kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Male patients having Androgenetic alopecia grade 2 to 5(Norwood Hamilton scale)
Age between 18 years and 45 years
Patients willing for the study, consent and follow up
Patients not on any other treatment for androgenetic alopecia for past 6 months
Patients below 18 years and above 45 years.
Female patients having androgenetic alopecia.
Concomitant dermatological disorders on the scalp other than androgenetic alopecia, serious cardiovascular disease, hepatic diseases, renal diseases.
History of treatment with systemic or locally acting medication which may interfere with the study objectives, such as minoxidil, finasteride treatment in the past 6 months or treatment with other hair growth products in the past 6months
Patients with unrealistic expectation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method assessed by measuring hair density, hair diameter, hair count per follicular unit, interfollicular distance, serial photographic assessmentTimepoint: every month for 6 months
- Secondary Outcome Measures
Name Time Method subjective satisfaction will be assessed by patients self assessment through the following set of questionnaries.Timepoint: after 6 months